moxalactam has been researched along with Blood Coagulation Disorders in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, X; Shen, J; Sun, X; Wu, W; Zhu, Y | 1 |
| Cai, Y; Wang, N; Wang, Y; Zhang, K; Zhang, L; Zhang, M | 1 |
| Gabor, EP; Lee, S; Spira, S | 1 |
| Clark, J; D'Elia, JA; Hochman, R; Kaldany, A; Miller, DG; Rolla, AR; Thomas, S | 1 |
| Adam, D; Naber, K; Schäfer, H | 1 |
| De Jongh, CA; Drusano, GL; Finley, RS; Joshi, JH; Moody, MR; Newman, KA; Salvatore, PC; Schimpff, SC; Tenney, JH; Thompson, BW | 1 |
| Ganzinger, U; Haberl, H; Haslberger, A; Hitzenberger, G; Schatz, F; Schiel, H | 1 |
| Baxter, JG; Marble, DA; Schentag, JJ; Walczak, P; Wels, PB; Whitfield, LR | 1 |
3 trial(s) available for moxalactam and Blood Coagulation Disorders
| Article | Year |
|---|---|
[Hemostasis disturbance caused by cephalosporins with an N-methylthiotetrazole side chain. A randomized pilot study].
Topics: Aged; Aged, 80 and over; Azoles; Blood Coagulation Disorders; Cefoperazone; Cefotaxime; Cephalosporins; Female; Humans; Male; Moxalactam; Pilot Projects; Protein C; Prothrombin Time; Random Allocation; Tetrazoles; Urinary Tract Infections; Vitamin K Deficiency | 1989 |
A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Blood Bactericidal Activity; Blood Coagulation Disorders; Clinical Trials as Topic; Drug Hypersensitivity; Drug Synergism; Drug Therapy, Combination; Fever; Hearing Disorders; Humans; Infections; Kanamycin; Kidney Diseases; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Neoplasms; Piperacillin; Random Allocation | 1986 |
Clinical risk factors for prolonged PT/PTT in abdominal sepsis patients treated with moxalactam or tobramycin plus clindamycin.
Topics: Abdomen; Adult; Aged; Blood Coagulation Disorders; Blood Coagulation Factors; Clindamycin; Drug Combinations; Female; Hemorrhage; Humans; Infections; Male; Middle Aged; Moxalactam; Partial Thromboplastin Time; Prospective Studies; Prothrombin Time; Random Allocation; Risk; Tobramycin; Vitamin K | 1985 |
5 other study(ies) available for moxalactam and Blood Coagulation Disorders
| Article | Year |
|---|---|
Latamoxef induced a severe coagulation disorder in older patients in China: Two case reports.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Blood Coagulation Disorders; Blood Coagulation Tests; Diagnosis, Differential; Humans; International Normalized Ratio; Male; Moxalactam; Partial Thromboplastin Time; Pneumonia, Bacterial | 2021 |
Latamoxef-induced coagulation disorders: Incidence and risk factors.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Blood Coagulation; Blood Coagulation Disorders; Ceftazidime; Comorbidity; Female; Hemorrhage; Humans; Incidence; Male; Middle Aged; Moxalactam; Retrospective Studies; Risk Factors; Sex Factors | 2021 |
Coagulopathy associated with moxalactam.
Topics: Adult; Aged; Blood Coagulation Disorders; Cephalosporins; Cephamycins; Female; Humans; Male; Moxalactam | 1983 |
Coagulopathy associated with the use of cephalosporin or moxalactam antibiotics in acute and chronic renal failure.
Topics: Acute Kidney Injury; Adult; Aged; Blood Coagulation Disorders; Cephalosporins; Female; Humans; Hypoprothrombinemias; Kidney Failure, Chronic; Male; Middle Aged; Moxalactam; Peritoneal Dialysis; Prothrombin Time; Renal Dialysis | 1983 |
Comparative pharmacokinetic analysis of latamoxef and CPW 86-363, a novel carboxy-pyrazol-cephalosporin and formation of N-methyl-thiotetrazole.
Topics: Adult; Azoles; Biotransformation; Blood Coagulation Disorders; Cephalosporins; Humans; Kinetics; Male; Moxalactam; Structure-Activity Relationship; Tetrazoles | 1987 |